UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
Read moreUK shareholder meetings calendar - next 7 days
Read moreIN BRIEF: Fidelity Japan Trust Net Asset Value Rises In First Half
Read moreUK EXECUTIVE CHANGE SUMMARY: Arkle Resources CEO Departs Immediately
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreFidelity Japan Trust Significantly Outperforms Benchmark In 2019
Read moreHansard Global Appoints Former Investment Banker Philip Kay To Board
Read more(Sharecast News) - In his 'Inside the City' column for the Sunday Times, Sam Chambers started by describing activist short sellers as "financial vigilantes", who spend months poring over a firm's books before publishing a "damning dossier", in a bid to put the kibosh on its share price.
Read moreAsia-Focused Specialist Funds Rise In September - QuotedData
Read more(Alliance News) - Fidelity Japan Trust PLC on Thursday reported a rise in net assets in the first half, outperforming its benchmark.At June 30, the trust's NAV per share stood at 159.35
Read moreLONDON (Alliance News) - Fidelity Japan Trust PLC on Friday said it underperformed its benchmark after its net asset value per share dropped 15%.For 2018, the company's NAV per share to
Read moreLONDON (Alliance News) - Fidelity Japan Trust PLC on Tuesday said it outperformed its benchmark in the first half of the year due to particularly strong growth among the retail, healthcare and in
Read moreWednesday 16 MayIndiviorNational Express GroupMondiMerchants Fund Big Box Trust Court
Read moreLONDON (Alliance News) - Fidelity Japanese Values PLC said on Thursday it outperformed its benchmark index over 2017 as Japanese equities put in a strong trust posted a net of
Read more* FTSE 100 down 0.4 pct at close * Indivior tumbles 6 pct after patent litigation loss * GSK up after exits Pfizer consumer health bid * Asia-exposed at -
Read more(For a live blog on European stocks, type LIVE/ in an Eikon news window) * FTSE 100 down 1 pct * Indivior tumbles 5 pct after patent litigation loss * Smiths Group down 11 GSK
Read more